You are here
Novartis begins trial of new antimalarial drug
NOVARTIS is taking aim at drug-resistant malaria - a growing global problem - by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.
The Swiss drugmaker, which is working on the mid-stage Phase IIb trial
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org